Browsing Tag
Satera
1 post
Axon Therapies just landed $32mn and a new CEO—can an implant-free heart failure therapy really change the game?
Find out how Axon Therapies’ $32M Series A and new CEO could speed implant-free heart failure trials and European expansion—see what it means for patients.